Predictive Technology Group

18 articles about Predictive Technology Group

• Predictive Technology Group and Manufacturing Partners Provide Updates of Its Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care

  3/30/2020

  Company provides formal response to misleading recently published short report

• Predictive Technology Group Announces Launch of Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care

  3/25/2020

  Assurance AB™ is a single-use, self-contained SARS-CoV-2 (COVID-19) antibody detection test that provides results in 15-minutes.

• Predictive Technology Group Announces Beta Test Results for its ARTguide™ Test

  2/11/2020

  Predictive Technology Group announced that its wholly owned subsidiary, Predictive Laboratories, received interim beta test results from its ARTguide™ test evaluating over 1,000 patients for risk of endometriosis at beta clinical sites.

• Predictive Technology Group and Atrin Pharmaceuticals Announce Molecular Diagnostic Oncology Development Collaboration

  1/28/2020

  Predictive Technology Group (OTC PINK: PRED) and Atrin Pharmaceuticals LLC are entering into a collaboration agreement to develop molecular diagnostic tools to facilitate improved selection of cancer patients who would most benefit from treatment with DNA Damage and Response (DDR) inhibitors, including Atrin’s and other small molecule ATR inhibitors

• Predictive Technology Group Reports First Quarter Fiscal 2020 Financial Results and Provides Corporate Update

  11/14/2019

  Predictive Technology is a leader in the development of genetic and molecular diagnostics and companion therapeutics

• Predictive Technologies Group Engages LifeSci Partners as Communications PartnerLifeSci to develop and execute comprehensive public relations and investor relations programs

  10/31/2019

  Predictive Technology Group, Inc., a leader in the development of genetic and molecular diagnostics and companion therapeutics, announced that it has engaged with LifeSci Partners to increase awareness of the company’s brand and clinical programs.

• Predictive Technologies Group PRED Upgrades to OTCQX® Best Market

  10/24/2019

  Predictive Technology Group, Inc., a leader in the development of genetic and molecular diagnostics and companion therapeutics, announced that the company has been upgraded to the OTCQX® Best Market from the Pink® market.

• Predictive Laboratories Announces Commercialization & Full Market Availability Of ARTguide™ At American Society Of Reproductive Medicine (ASRM) Scientific Congress & ExpoCompany also presenting 2 oral & 1 poster scientific presentations at ASRM

  10/10/2019

  Predictive Laboratories, a wholly owned molecular and genetic diagnostics company of Predictive Technology Group focused on hard-to-detect diseases, women’s health and infertility, announces the commercialization and full market availability of ARTguide, the first integrated, DNA-based test that evaluates the risk for endometriosis and other genetic causes of infertility in women.

• Predictive Diagnostics Launches Endometriosis Risk Test

  10/4/2018

  Predictive Technology Group, (OTC/PINK: PRED), a leader in the use of data analytics for disease identification enabling revolutionary therapeutic approaches, announces that its subsidiary, Predictive Diagnostics, will launch a unique endometriosis risk test this weekend at the 74th American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo in Denver, Colorado.

• Predictive Technology Group Acquires Key DNA and Ancestry Assets

  10/2/2018

  Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments, announces that it has acquired DNA and ancestry assets, including significant genetic data related to women’s diseases and degenerative disc disease from Taueret Laboratories, LLC

• Predictive Technology Group Appoints Ronald Barhorst to Chair Its Financial Advisory Board

  2/1/2018

  Mr. Barhorst brings in depth finance and governance experience gained during a career in the financial markets.

• Predictive Technology Group Appoints Dr. Gregory A. Prince to Its Scientific Advisory Board

  1/17/2018

  As a co-founder and CEO of Virion Systems, Inc., Dr. Prince brings pharmaceutical research and development and commercialization expertise to the Scientific Advisory Board team.

• Predictive Technology Group (PRED) Appoints John C. Nelson, M.D., M.P.H. to the Predictive Technology Group Scientific Advisory Board

  1/11/2018

  Dr. Nelson served as President of the American Medical Association, Salt Lake County Medical Society, and the Utah Medical Association.

• Predictive Technology Group Finalizes Letter of Intent to Acquire FlagshipHealth Group

  1/10/2018

  The deal allows Predictive Technology Group to develop, launch, and grow its services directed at limiting disease and improving the health and well-being of individuals confronting a wide-range of medical conditions.

• Predictive Technology Group Appoints Dr. Hugh S. Taylor, M.D. to the Predictive Technology Group's Scientific Advisory Board

  1/4/2018

  Dr. Taylor’s teaches as Professor of Molecular, Cellular and Developmental Biology at Yale University.

• Predictive Technology Group Appoints Dr. Michael Dey To Board Of Directors

  1/2/2018

  In addition to serving as a PRED Board Member, Dr. Dey will continue as Chief Executive Officer of Predicitive Therapeutics, Inc., a wholly owned subsidiary of PRED.

• Predictive Technology Group Announces Issuance of U.S. Patent for Method of Treating Endometriosis

  12/28/2017

  The patent covers any treatment of endometriosis in women, whether symptomatic or not, having any one (or more) of approximately 1,400 endometriosis-associated midwegenetic markers.

• Predictive Technology Group Evaluates Up-Listing Trading Status To OTCQB

  9/11/2017